Comparison of Top Two Shares of the Day: Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Vulcan Materials Company (NYSE:VMC)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) closed at $142.19 on the last trading session with an increase of 1.27%, whereas, it previously closed at $140.41. The company has a market capitalization of $8.62 Billion. The company traded shares of 1.74 Million on the trading day while its three month average volume stands at 511.67 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) produced diluted EPS of 4.55. The EPS estimate for next year as estimated by analysts is at 14.98 while EPS for next quarter is estimated at 3.32. Earnings per Share growth for this year is reported at -15.4, while the analysts estimated the EPS growth for next year at 14.98% and Earnings growth for next 5 years stands at 16.2% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 4.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is at 31.26 while the forward p/e is at 9.49. The P/S or Price to Sales ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 4.81 and Price to Book or P/B for the most recent quarter stands at 2.98. The Price to Free Cash Flow ratio or P/FCF is reported at 16.43. The quick ratio and the current ratio of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are reported at 3.6 and 3.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stands at 8.4, 16 and 9.8 respectively

The trailing twelve month Revenue of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is reported at 1.79 Billion with income of 278.9 Million. The outstanding shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are 60.65 Million. The institutional Ownership of the shares of 97.8 stands at 0.80%, this figure is decreased -0.44 in the last six months. The insider ownership for the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is ticked at 2.5%, the figure is plummeted -4% in the last six months.

Some other important financial aspects to be discussed here for Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is the Mean Target Price estimated by the analysts which stands at 194.89. The 52 week high of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is placed at 184.00 and 52 week low is standing at 130.15.

Performance wise the shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) fell down -13.15% for the week, it also fell -12.23% for the monthly performance, while for the quarter it went up -19.26%. The shares decrease -13.52% for the half year and flew up for the Year-To-Date performance. The shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) grew 4.24% for the yearly performance.

Vulcan Materials Company (NYSE:VMC)

Vulcan Materials Company (NYSE:VMC) closed at $107.98 on the last trading session with an decrease of -1.12%, whereas, it previously closed at $109.2. The company has a market capitalization of $14.43 Billion. The company traded shares of 1.74 Million on the trading day while its three month average volume stands at 1.54 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Vulcan Materials Company (NYSE:VMC) produced diluted EPS of 3.17. The EPS estimate for next year as estimated by analysts is at 4.96 while EPS for next quarter is estimated at 0.92. Earnings per Share growth for this year is reported at -29.4, while the analysts estimated the EPS growth for next year at 4.96% and Earnings growth for next 5 years stands at 25.85% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 48.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Vulcan Materials Company (NYSE:VMC) is at 34.08 while the forward p/e is at 21.79. The P/S or Price to Sales ratio of Vulcan Materials Company (NYSE:VMC) stands at 3.38 and Price to Book or P/B for the most recent quarter stands at 2.78. The Price to Free Cash Flow ratio or P/FCF is reported at 358.02. The quick ratio and the current ratio of Vulcan Materials Company (NYSE:VMC) are reported at 1.1 and 1.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Vulcan Materials Company (NYSE:VMC) stands at 4.6, 8.9 and 7.4 respectively

The trailing twelve month Revenue of Vulcan Materials Company (NYSE:VMC) is reported at 4.27 Billion with income of 424.5 Million. The outstanding shares of Vulcan Materials Company (NYSE:VMC) are 133.62 Million. The institutional Ownership of the shares of 99.54 stands at 0.80%, this figure is increased 0.5 in the last six months. The insider ownership for the shares of Vulcan Materials Company (NYSE:VMC) is ticked at 0.1%, the figure is plummeted -25.28% in the last six months.

Some other important financial aspects to be discussed here for Vulcan Materials Company (NYSE:VMC) is the Mean Target Price estimated by the analysts which stands at 123.46. The 52 week high of Vulcan Materials Company (NYSE:VMC) is placed at 141.20 and 52 week low is standing at 82.52.

Performance wise the shares of Vulcan Materials Company (NYSE:VMC) rose up 5.09% for the week, it also rise 2.59% for the monthly performance, while for the quarter it went up -2.29%. The shares decrease -15.22% for the half year and plummeted for the Year-To-Date performance. The shares of Vulcan Materials Company (NYSE:VMC) shrinked -12.85% for the yearly performance.